Showing results (51-60 of 96) with videos related to
Sort By:
Pageof 10
Clinical Neuropharmacology|December 20, 2007
Ziprasidone-associated depressive state in schizophrenic patientsAlexander Kaptsan, Tzvi Dwolatzky, Vladimir LernerMedical Hypotheses|November 11, 2011
Perverse political correctness and personality traitsAlexander Neduva, Michael Kanevsky, Vladimir LernerThe Israel Journal of Psychiatry and Related Sciences|August 17, 2006
Tattoo designs among drug abusersAlexander Borokhov, Roland Bastiaans, Vladimir LernerInternational Journal of Psychiatry in Medicine|May 22, 2004
High-dose olanzapine-induced improvement of preexisting type 2 diabetes mellitus in schizophrenic patientsVladimir Lerner, Igor Libov, Michael KanevskyClinical Neuropharmacology|June 21, 2005
Quetiapine-associated depression in a patient with schizophreniaJoseph Mergui, Sol Jaworowski, Vladimir LernerPsychiatry and Clinical Neurosciences|January 6, 2015
Tardive dyskinesia (syndrome): Current concept and modern approaches to its managementPaul P Lerner, Chanoch Miodownik, Vladimir LernerFrontiers in Psychiatry|March 19, 2020
Extreme Risk-Taking Behaviors in Patients With Eating DisordersDaniel Stein, Shikma Keller, Inbar Sharav Ifergan, et al.Harefuah|October 2, 2003
[Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders]Chanoch Miodownik, Hagit Cohen, Moshe Kotler, et al.Clinical Neuropharmacology|June 4, 2008
Delirium associated with lithium-quetiapine combinationChanoch Miodownik, Awad Alkatnany, Katherina Frolova, et al.The Journal of Clinical Psychiatry|January 27, 2005
Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disordersJoseph Bergman, Tzvi Dwolatzky, Izidor Brettholz, et al.Pageof 10